EnteroBiotix
Edinburgh
About EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome-modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $55.2M
- Last round: Series Unknown (Jul 2025)
- Website: enterobiotix.com
- Phone: 00441698501370
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/enterobiotix-61025 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.